Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15856 | 619 | 40.9 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | THYMUS AND ACTIVATION REGULATED CHEMOKINE | Author keyword | 26 | 63% | 4% | 26 |
2 | TARC | Author keyword | 24 | 43% | 7% | 43 |
3 | CCR4 | Author keyword | 18 | 33% | 7% | 45 |
4 | CTACK | Author keyword | 12 | 86% | 1% | 6 |
5 | CCR8 | Author keyword | 12 | 59% | 2% | 13 |
6 | MACROPHAGE DERIVED CHEMOKINE | Author keyword | 11 | 52% | 2% | 15 |
7 | CCL17 | Author keyword | 10 | 38% | 3% | 21 |
8 | CCL22 | Author keyword | 10 | 38% | 3% | 21 |
9 | I 309 | Author keyword | 8 | 75% | 1% | 6 |
10 | TARC CCL17 | Author keyword | 7 | 56% | 1% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THYMUS AND ACTIVATION REGULATED CHEMOKINE | 26 | 63% | 4% | 26 | Search THYMUS+AND+ACTIVATION+REGULATED+CHEMOKINE | Search THYMUS+AND+ACTIVATION+REGULATED+CHEMOKINE |
2 | TARC | 24 | 43% | 7% | 43 | Search TARC | Search TARC |
3 | CCR4 | 18 | 33% | 7% | 45 | Search CCR4 | Search CCR4 |
4 | CTACK | 12 | 86% | 1% | 6 | Search CTACK | Search CTACK |
5 | CCR8 | 12 | 59% | 2% | 13 | Search CCR8 | Search CCR8 |
6 | MACROPHAGE DERIVED CHEMOKINE | 11 | 52% | 2% | 15 | Search MACROPHAGE+DERIVED+CHEMOKINE | Search MACROPHAGE+DERIVED+CHEMOKINE |
7 | CCL17 | 10 | 38% | 3% | 21 | Search CCL17 | Search CCL17 |
8 | CCL22 | 10 | 38% | 3% | 21 | Search CCL22 | Search CCL22 |
9 | I 309 | 8 | 75% | 1% | 6 | Search I+309 | Search I+309 |
10 | TARC CCL17 | 7 | 56% | 1% | 9 | Search TARC+CCL17 | Search TARC+CCL17 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MACROPHAGE DERIVED CHEMOKINE | 66 | 38% | 23% | 140 |
2 | TARC | 52 | 65% | 8% | 50 |
3 | ACTIVATION REGULATED CHEMOKINE | 47 | 34% | 18% | 113 |
4 | RECEPTORS CCR4 | 22 | 81% | 2% | 13 |
5 | I 309 | 12 | 58% | 2% | 14 |
6 | CC CHEMOKINE | 11 | 13% | 12% | 75 |
7 | RECEPTOR CCR4 | 11 | 69% | 1% | 9 |
8 | MDC | 10 | 46% | 3% | 16 |
9 | CHEMOKINE RECEPTORS CCR4 | 9 | 48% | 2% | 14 |
10 | SKIN ASSOCIATED CHEMOKINE | 8 | 32% | 3% | 20 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis | 2014 | 6 | 32 | 47% |
Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases | 2006 | 86 | 46 | 57% |
T cell homing to epithelial barriers in allergic disease | 2012 | 50 | 161 | 27% |
T cell trafficking in allergic asthma: The ins and outs | 2008 | 92 | 163 | 18% |
Antagonists of CCR4 as immunomodulatory agents | 2006 | 19 | 82 | 59% |
Chemokine networks in atopic dermatitis: Traffic signals of disease | 2005 | 35 | 50 | 44% |
Allergic asthma: a tale of many T cells | 2008 | 47 | 129 | 14% |
Targeting chemokine receptors in allergic disease | 2011 | 21 | 210 | 18% |
Chemokines in tissue-specific and microenvironment-specific lymphocyte homing | 2000 | 428 | 43 | 12% |
Functional chemokine receptors in allergic diseases: Is CCR8 a novel therapeutic target? | 2006 | 4 | 42 | 48% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | P TAU | 1 | 40% | 0.3% | 2 |
2 | ALLERGYBIOMOL SECRET | 1 | 50% | 0.2% | 1 |
3 | BEREICH EXPT PNEUMOL | 1 | 50% | 0.2% | 1 |
4 | BIOMOL RECOGNIT OPHTALMOL | 1 | 50% | 0.2% | 1 |
5 | CEMDR | 1 | 50% | 0.2% | 1 |
6 | CORE EVOLUT TECHNOL C T | 1 | 50% | 0.2% | 1 |
7 | FOOD COSMET CONTROL | 1 | 50% | 0.2% | 1 |
8 | HB WELLS PEDIAT PHARMACOL TOXICOL | 1 | 50% | 0.2% | 1 |
9 | IMMUNOLMINIST HLTH | 1 | 50% | 0.2% | 1 |
10 | LEUKOCYTE BIOL SECT HEART LUNG | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000283388 | EOTAXIN//CCR3//RANTES |
2 | 0.0000250285 | CCL20//CCR6//MACROPHAGE INFLAMMATORY PROTEIN 3 ALPHA |
3 | 0.0000239198 | CHEMOKINE LIKE FACTOR 1//CKLF1//CMTM5 |
4 | 0.0000175819 | CCR2 ANTAGONIST//CCR2//CCR2 ANTAGONISTS |
5 | 0.0000165567 | CXCR3//CXCL10//CXCL9 |
6 | 0.0000163046 | BB 10010//CK BETA 8//STEM CELL INHIBITOR |
7 | 0.0000118271 | ATOPIC DERMATITIS//FILAGGRIN//ATOPIC MARCH |
8 | 0.0000088943 | IMMUNOBIOL ROBERT H LURIE CANC//EXPT CLIN NEUROL//MS CLIN |
9 | 0.0000087272 | CCR9//CCL28//ANTIGEN P ENTAT GRP |
10 | 0.0000078797 | DUFFY BLOOD GROUP//DARC//DUFFY ANTIGEN |